Literature DB >> 16372391

Sample sizes for self-controlled case series studies.

Patrick Musonda1, C Paddy Farrington, Heather J Whitaker.   

Abstract

We derive several formulae for the sample size required for a study designed using the self-controlled case series method without age effects. We investigate these formulae by simulation, and identify one based on the signed root likelihood ratio statistic which performs well. We extend this method to allow for age effects, which can have a big impact on the sample size needed. This more general sample size formula is also found to perform well in a broad range of situations. Copyright 2006 John Wiley & Sons, Ltd.

Mesh:

Substances:

Year:  2006        PMID: 16372391     DOI: 10.1002/sim.2477

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  23 in total

1.  Telephone monitoring of adverse events during an MF59®-adjuvanted H5N1 influenza vaccination campaign in Taiwan.

Authors:  Wan-Ting Huang; Chih-Hsi Chang; Mei-Chen Peng
Journal:  Hum Vaccin Immunother       Date:  2013-10-08       Impact factor: 3.452

2.  The impact of drug and outcome prevalence on the feasibility and performance of analytical methods for a risk identification and analysis system.

Authors:  Christian G Reich; Patrick B Ryan; Marc A Suchard
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

3.  The risk of falls on initiation of antihypertensive drugs in the elderly.

Authors:  D A Butt; M Mamdani; P C Austin; K Tu; T Gomes; R H Glazier
Journal:  Osteoporos Int       Date:  2013-04-24       Impact factor: 4.507

4.  Vaccines are not associated with metabolic events in children with urea cycle disorders.

Authors:  Thomas M Morgan; Cameron Schlegel; Kathryn M Edwards; Teresa Welch-Burke; Yuwei Zhu; Robert Sparks; Marshall Summar
Journal:  Pediatrics       Date:  2011-04-11       Impact factor: 7.124

5.  Live attenuated influenza vaccine use and safety in children and adults with asthma.

Authors:  Jonathan Duffy; Melissa Lewis; Theresa Harrington; Roger Baxter; Edward A Belongia; Lisa A Jackson; Steven J Jacobsen; Grace M Lee; Allison L Naleway; James Nordin; Matthew F Daley
Journal:  Ann Allergy Asthma Immunol       Date:  2017-04       Impact factor: 6.347

6.  Infective endocarditis following invasive dental procedures: IDEA case-crossover study.

Authors:  Martin H Thornhill; Annabel Crum; Saleema Rex; Richard Campbell; Tony Stone; Mike Bradburn; Veronica Fibisan; Mark J Dayer; Bernard D Prendergast; Peter B Lockhart; Larry M Baddour; Jon Nicholl
Journal:  Health Technol Assess       Date:  2022-05       Impact factor: 4.106

7.  Design considerations for case series models with exposure onset measurement error.

Authors:  Sandra M Mohammed; Lorien S Dalrymple; Damla Sentürk; Danh V Nguyen
Journal:  Stat Med       Date:  2012-08-22       Impact factor: 2.373

8.  Association between oral fluoroquinolones and seizures: A self-controlled case series study.

Authors:  Celine S L Chui; Esther W Chan; Angel Y S Wong; Adrian Root; Ian J Douglas; Ian C K Wong
Journal:  Neurology       Date:  2016-04-06       Impact factor: 9.910

Review 9.  Case-only designs in pharmacoepidemiology: a systematic review.

Authors:  Sandra Nordmann; Lucie Biard; Philippe Ravaud; Marina Esposito-Farèse; Florence Tubach
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

Review 10.  Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.

Authors:  Ole Jakob Storebø; Nadia Pedersen; Erica Ramstad; Maja Lærke Kielsholm; Signe Sofie Nielsen; Helle B Krogh; Carlos R Moreira-Maia; Frederik L Magnusson; Mathilde Holmskov; Trine Gerner; Maria Skoog; Susanne Rosendal; Camilla Groth; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Sasja J Håkonsen; Lise Aagaard; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2018-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.